Leslie Meltzer, PhD, is an award-winning Medical Affairs leader with proven track record of strategic and operational success across broad range of functions (Medical Director, Medical Information, MSL Training, Medical Communications, Phase IV research, KOL engagement/advisory board management) and therapeutic areas (neurology, cardiology, pulmonology, hematology, rare disease, renal disease). She has a strong record of successful product launch strategies in Medical Affairs, having launched 3 products in the past 6 years. Further, she is a well-established strategic leader in Medical Affairs, with a focus on strategic data generation and communication planning at the affiliate level for the launch period and beyond. Her highly effective cross-functional collaborator, with strong working relationships with commercial, advocacy relations, medical education, policy and health economics/market access lead to flawless execution and operational excellence. Importantly, she brings expertise in late stage clinical and real-world outcomes studies, with a focus on prospective and retrospective observational studies to address real world unmet medical needs. Recently, Dr. Meltzer was recognized on the Endpoints News 20 Under 40 in Biopharma special report list.